$INBS Income Statement | Understand Stock

$INBS

$1.64 +$0.05 (3.14%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2026 12 months to Jun 30, 2026	FY2025 12 months to Jun 30, 2025	FY2024 12 months to Jun 30, 2024	FY2023 12 months to Jun 30, 2023	FY2022 12 months to Jun 30, 2022
Revenue
Cost of revenue (exclusive of amortization shown separately below)
Gross profit
Other income
Government support income
Operating expenses
Selling, general and administrative expenses
Development and regulatory approval expenses
Depreciation and amortization
Goodwill impairment
Impairment of long-lived assets
Total operating expenses

Loss from operations
Other income (expense), net
Interest expense
Realized foreign exchange gain (loss)
Fair value gain on revaluation of financial instrument
Interest income
Total other income, net
Net loss
Net loss attributable to non-controlling interest
Net loss attributable to Intelligent Bio Solutions Inc.
Other comprehensive (loss) income
Foreign currency translation (loss) gain
Total other comprehensive (loss) income
Comprehensive loss
Comprehensive loss attributable to non-controlling interest
Comprehensive loss attributable to Intelligent Bio Solutions Inc.
Net loss per share, basic
Net loss per share, diluted
Weighted average shares outstanding, basic
Weighted average shares outstanding, diluted

Comments